| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Thilo van Eimeren, Bénédicte Ballanger, Giovanna Pellecchia, Janis M Miyasaki, Anthony E Lang, Antonio P Strafell. Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease? Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 34. issue 13. 2010-01-19. PMID:19741594. |
we tested the hypothesis that tonic stimulation of dopamine receptors specifically desensitizes the dopaminergic reward system by preventing decreases in dopaminergic transmission that occurs with negative feedback. |
2010-01-19 |
2023-08-12 |
Not clear |
| Natalia Omelchenko, Roland Bell, Susan R Sesac. Lateral habenula projections to dopamine and GABA neurons in the rat ventral tegmental area. The European journal of neuroscience. vol 30. issue 7. 2010-01-18. PMID:19788571. |
ventral tegmental area (vta) dopamine (da) neurons and their forebrain projections are critically involved in reward processing and cognitive functions. |
2010-01-18 |
2023-08-12 |
rat |
| Nikhil K Parelkar, Qian Jiang, Xiang-Ping Chu, Ming-Lei Guo, Li-Min Mao, John Q Wan. Amphetamine alters Ras-guanine nucleotide-releasing factor expression in the rat striatum in vivo. European journal of pharmacology. vol 619. issue 1-3. 2010-01-14. PMID:19686726. |
while the ras-mapk cascade in the limbic reward circuit is well-known to be sensitive to dopamine inputs, the sensitivity of its upstream activator (ras-grfs) to dopamine remains to be investigated. |
2010-01-14 |
2023-08-12 |
human |
| Sonia Bernal, Patricia Miner, Yana Abayev, Ester Kandova, Meri Gerges, Khalid Touzani, Anthony Sclafani, Richard J Bodna. Role of amygdala dopamine D1 and D2 receptors in the acquisition and expression of fructose-conditioned flavor preferences in rats. Behavioural brain research. vol 205. issue 1. 2010-01-12. PMID:19573566. |
given the role of dopamine in the amygdala (amy) in the processing and learning of food reward, the present study examined whether dopamine d1-like or d2-like antagonists in this site altered acquisition and/or expression of a fructose-cfp. |
2010-01-12 |
2023-08-12 |
rat |
| Clara Velázquez-Sánchez, Antonio Ferragud, Vicente Hernández-Rabaza, Amparo Nácher, Virginia Merino, Miguel Cardá, Juan Murga, Juan J Canale. The dopamine uptake inhibitor 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 34. issue 12. 2010-01-12. PMID:19606084. |
the dopamine uptake inhibitor 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward. |
2010-01-12 |
2023-08-12 |
mouse |
| Kimberly H Ludlow, Katie D Bradley, David W Allison, Seth R Taylor, Jordan T Yorgason, David M Hansen, Christine H Walton, Sterling N Sudweeks, Scott C Steffense. Acute and chronic ethanol modulate dopamine D2-subtype receptor responses in ventral tegmental area GABA neurons. Alcoholism, clinical and experimental research. vol 33. issue 5. 2010-01-11. PMID:19298327. |
ventral tegmental area (vta) gamma-aminobutyric acid (gaba) neurons appear to be critical substrates underlying the acute and chronic effects of ethanol on dopamine (da) neurotransmission in the mesocorticolimbic system implicated in drug reward. |
2010-01-11 |
2023-08-12 |
Not clear |
| J Yacubian, C Büche. The genetic basis of individual differences in reward processing and the link to addictive behavior and social cognition. Neuroscience. vol 164. issue 1. 2010-01-11. PMID:19446009. |
consequently, genetic variations of dopamine neurotransmission are thought influence reward processing that in turn may affect distinctive social behavior and susceptibility to addiction. |
2010-01-11 |
2023-08-12 |
Not clear |
| Jerylin O Gan, Mark E Walton, Paul E M Phillip. Dissociable cost and benefit encoding of future rewards by mesolimbic dopamine. Nature neuroscience. vol 13. issue 1. 2010-01-08. PMID:19904261. |
reward-predicting cues evoke activity in midbrain dopamine neurons that encodes fundamental attributes of economic value, including reward magnitude, delay and uncertainty. |
2010-01-08 |
2023-08-12 |
rat |
| Milan Joksimovic, Angela Anderegg, Anil Roy, Laura Campochiaro, Beth Yun, Raja Kittappa, Ronald McKay, Rajeshwar Awatraman. Spatiotemporally separable Shh domains in the midbrain define distinct dopaminergic progenitor pools. Proceedings of the National Academy of Sciences of the United States of America. vol 106. issue 45. 2010-01-06. PMID:19850875. |
midbrain dopamine neurons (mda) are important regulators of diverse physiological functions, including movement, attention, and reward behaviors. |
2010-01-06 |
2023-08-12 |
Not clear |
| Stefano Palminteri, Maël Lebreton, Yulia Worbe, David Grabli, Andreas Hartmann, Mathias Pessiglion. Pharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes. Proceedings of the National Academy of Sciences of the United States of America. vol 106. issue 45. 2010-01-06. PMID:19850878. |
conversely, blocking dopamine transmission in ts patients favored punishment avoidance but impaired reward seeking. |
2010-01-06 |
2023-08-12 |
Not clear |
| Allison A Feduccia, Christine L Duvauchell. Auditory stimuli enhance MDMA-conditioned reward and MDMA-induced nucleus accumbens dopamine, serotonin and locomotor responses. Brain research bulletin. vol 77. issue 4. 2010-01-05. PMID:18722516. |
auditory stimuli enhance mdma-conditioned reward and mdma-induced nucleus accumbens dopamine, serotonin and locomotor responses. |
2010-01-05 |
2023-08-12 |
rat |
| Liam Nestor, Robert Hester, Hugh Garava. Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users. NeuroImage. vol 49. issue 1. 2010-01-04. PMID:19631753. |
the reward deficiency syndrome (rds) of addiction posits that there are deficits in dopamine (da) motivational circuitry for non-drug rewards, such that only drugs of abuse are capable of normalizing da in the ventral striatum (vs). |
2010-01-04 |
2023-08-12 |
Not clear |
| Henrik Walter, Hannes Kammerer, Karel Frasch, Manfred Spitzer, Birgit Able. Altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia. Psychopharmacology. vol 206. issue 1. 2009-12-29. PMID:19521678. |
altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia. |
2009-12-29 |
2023-08-12 |
Not clear |
| Robb B Rutledge, Stephanie C Lazzaro, Brian Lau, Catherine E Myers, Mark A Gluck, Paul W Glimche. Dopaminergic drugs modulate learning rates and perseveration in Parkinson's patients in a dynamic foraging task. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 29. issue 48. 2009-12-22. PMID:19955362. |
we also found a novel dopamine-dependent effect on decision making that is not accounted for by reinforcement learning models: perseveration in choice, independent of reward history, increases with parkinson's disease and decreases with dopamine therapy. |
2009-12-22 |
2023-08-12 |
Not clear |
| K Ornstein, J P Husto. Influence of 6-hydroxydopamine injections in the substantia nigra on lateral hypothalamic reinforcement. Neuroscience letters. vol 1. issue 6. 2009-12-15. PMID:19604801. |
hence, nigrostriatal dopamine is unlikely to be critically involved in operant learning and reward processes. |
2009-12-15 |
2023-08-12 |
rat |
| Nikoletta Bódi, Szabolcs Kéri, Helga Nagy, Ahmed Moustafa, Catherine E Myers, Nathaniel Daw, György Dibó, Annamária Takáts, Dániel Bereczki, Mark A Gluc. Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients. Brain : a journal of neurology. vol 132. issue Pt 9. 2009-12-14. PMID:19416950. |
results revealed that never-medicated patients with parkinson's disease showed selective deficits on reward processing and novelty seeking, which were remediated by dopamine agonists. |
2009-12-14 |
2023-08-12 |
Not clear |
| Nikoletta Bódi, Szabolcs Kéri, Helga Nagy, Ahmed Moustafa, Catherine E Myers, Nathaniel Daw, György Dibó, Annamária Takáts, Dániel Bereczki, Mark A Gluc. Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients. Brain : a journal of neurology. vol 132. issue Pt 9. 2009-12-14. PMID:19416950. |
in addition, dopamine agonists increased the correlation between reward processing and novelty seeking, whereas these drugs decreased the correlation between punishment processing and harm avoidance. |
2009-12-14 |
2023-08-12 |
Not clear |
| Nikoletta Bódi, Szabolcs Kéri, Helga Nagy, Ahmed Moustafa, Catherine E Myers, Nathaniel Daw, György Dibó, Annamária Takáts, Dániel Bereczki, Mark A Gluc. Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients. Brain : a journal of neurology. vol 132. issue Pt 9. 2009-12-14. PMID:19416950. |
our finding that dopamine agonist administration in young patients with parkinson's disease resulted in increased novelty seeking, enhanced reward processing, and decreased punishment processing may shed light on the cognitive and personality bases of the impulse control disorders, which arise as side-effects of dopamine agonist therapy in some parkinson's disease patients. |
2009-12-14 |
2023-08-12 |
Not clear |
| Birgit Abler, Roman Hahlbrock, Alexander Unrath, Georg Grön, Jan Kassube. At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists. Brain : a journal of neurology. vol 132. issue Pt 9. 2009-12-14. PMID:19567700. |
at-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists. |
2009-12-14 |
2023-08-12 |
Not clear |
| Sondra T Bland, Mark R Hutchinson, Steven F Maier, Linda R Watkins, Kirk W Johnso. The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release. Brain, behavior, and immunity. vol 23. issue 4. 2009-12-09. PMID:19486648. |
the present studies extend this line of investigation by exploring whether glial activation may also affect extracellular levels of dopamine (da) in the nucleus accumbens (nac) shell, a neurochemical corollary of morphine-induced drug reward, during a challenge dose of morphine in experiments both with and without precipitated withdrawal. |
2009-12-09 |
2023-08-12 |
rat |